title: Polymorphisms in inflammation pathway genes and endometrial cancer risk.
abstract: BACKGROUND
  Experimental and epidemiologic evidence have suggested that chronic inflammation may play a critical role in endometrial carcinogenesis.
  
  
  METHODS
  To investigate this hypothesis, a two-stage study was carried out to evaluate single-nucleotide polymorphisms (SNP) in inflammatory pathway genes in association with endometrial cancer risk. In stage I, 64 candidate pathway genes were identified and 4,542 directly genotyped or imputed SNPs were analyzed among 832 endometrial cancer cases and 2,049 controls, using data from the Shanghai Endometrial Cancer Genetics Study. Linkage disequilibrium of stage I SNPs significantly associated with endometrial cancer (P < 0.05) indicated that the majority of associations could be linked to one of 24 distinct loci. One SNP from each of the 24 loci was then selected for follow-up genotyping. Of these, 21 SNPs were successfully designed and genotyped in stage II, which consisted of 10 additional studies including 6,604 endometrial cancer cases and 8,511 controls.
  
  
  RESULTS
  Five of the 21 SNPs had significant allelic odds ratios (ORs) and 95% confidence intervals (CI) as follows: FABP1, 0.92 (0.85-0.99); CXCL3, 1.16 (1.05-1.29); IL6, 1.08 (1.00-1.17); MSR1, 0.90 (0.82-0.98); and MMP9, 0.91 (0.87-0.97). Two of these polymorphisms were independently significant in the replication sample (rs352038 in CXCL3 and rs3918249 in MMP9). The association for the MMP9 polymorphism remained significant after Bonferroni correction and showed a significant association with endometrial cancer in both Asian- and European-ancestry samples.
  
  
  CONCLUSIONS
  These findings lend support to the hypothesis that genetic polymorphisms in genes involved in the inflammatory pathway may contribute to genetic susceptibility to endometrial cancer. Impact statement: This study adds to the growing evidence that inflammation plays an important role in endometrial carcinogenesis.
authors.affiliation: Division of Epidemiology, Department of Medicineand Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
authors.forename: Ryan J
authors.initials: RJ
authors.lastname: Delahanty
authors.forename: Yong-Bing
authors.initials: YB
authors.lastname: Xiang
authors.forename: Amanda
authors.initials: A
authors.lastname: Spurdle
authors.forename: Alicia
authors.initials: A
authors.lastname: Beeghly-Fadiel
authors.forename: Jirong
authors.initials: J
authors.lastname: Long
authors.forename: Deborah
authors.initials: D
authors.lastname: Thompson
authors.forename: Ian
authors.initials: I
authors.lastname: Tomlinson
authors.forename: Herbert
authors.initials: H
authors.lastname: Yu
authors.forename: Diether
authors.initials: D
authors.lastname: Lambrechts
authors.forename: Thilo
authors.initials: T
authors.lastname: Dörk
authors.forename: Marc T
authors.initials: MT
authors.lastname: Goodman
authors.forename: Ying
authors.initials: Y
authors.lastname: Zheng
authors.forename: Helga B
authors.initials: HB
authors.lastname: Salvesen
authors.forename: Ping-Ping
authors.initials: PP
authors.lastname: Bao
authors.forename: Frederic
authors.initials: F
authors.lastname: Amant
authors.forename: Matthias W
authors.initials: MW
authors.lastname: Beckmann
authors.forename: Lieve
authors.initials: L
authors.lastname: Coenegrachts
authors.forename: An
authors.initials: A
authors.lastname: Coosemans
authors.forename: Natalia
authors.initials: N
authors.lastname: Dubrowinskaja
authors.forename: Alison
authors.initials: A
authors.lastname: Dunning
authors.forename: Ingo B
authors.initials: IB
authors.lastname: Runnebaum
authors.forename: Douglas
authors.initials: D
authors.lastname: Easton
authors.forename: Arif B
authors.initials: AB
authors.lastname: Ekici
authors.forename: Peter A
authors.initials: PA
authors.lastname: Fasching
authors.forename: Mari K
authors.initials: MK
authors.lastname: Halle
authors.forename: Alexander
authors.initials: A
authors.lastname: Hein
authors.forename: Kimberly
authors.initials: K
authors.lastname: Howarth
authors.forename: Maggie
authors.initials: M
authors.lastname: Gorman
authors.forename: Dylyara
authors.initials: D
authors.lastname: Kaydarova
authors.forename: Camilla
authors.initials: C
authors.lastname: Krakstad
authors.forename: Felicity
authors.initials: F
authors.lastname: Lose
authors.forename: Lingeng
authors.initials: L
authors.lastname: Lu
authors.forename: Galina
authors.initials: G
authors.lastname: Lurie
authors.forename: Tracy
authors.initials: T
authors.lastname: O'Mara
authors.forename: Rayna K
authors.initials: RK
authors.lastname: Matsuno
authors.forename: Paul
authors.initials: P
authors.lastname: Pharoah
authors.forename: Harvey
authors.initials: H
authors.lastname: Risch
authors.forename: Madeleine
authors.initials: M
authors.lastname: Corssen
authors.forename: Jone
authors.initials: J
authors.lastname: Trovik
authors.forename: Nurzhan
authors.initials: N
authors.lastname: Turmanov
authors.forename: Wanqing
authors.initials: W
authors.lastname: Wen
authors.forename: Wei
authors.initials: W
authors.lastname: Lu
authors.forename: Qiuyin
authors.initials: Q
authors.lastname: Cai
authors.forename: Wei
authors.initials: W
authors.lastname: Zheng
authors.forename: Xiao-Ou
authors.initials: XO
authors.lastname: Shu
mesh_terms: D044466:Asian People / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000235:genetics*; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D016889:Endometrial Neoplasms / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D005500:Follow-Up Studies; D020869:Gene Expression Profiling; D020022:Genetic Predisposition to Disease; D006801:Humans; D007249:Inflammation / Q000150:complications* / Q000235:genetics; D015810:Linkage Disequilibrium; D008875:Middle Aged; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011379:Prognosis; D012307:Risk Factors
chemical_list: D014408:Biomarkers, Tumor